The founder of one of Main Sequence’s first investments, medtech Maxwell Plus, on failure, timing, and being ahead of the pack
A retrospective on Maxwell Plus, a machine-vision prostate cancer medtech that folded, with founder Elliot Smith and investor Phil Morle sharing lessons; Harrison.ai's later raise underscores the timing they missed.
Also Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Forbes Australia·Forbes Australia